Suzuken Co., Ltd. (TYO:9987)
Japan · Delayed Price · Currency is JPY 6,414.00
+38.00 (0.60%)
Mar 5, 2026, 3:30 PM JST
Suzuken Revenue
Suzuken had revenue of 666.19B JPY in the quarter ending December 31, 2025, with 3.87% growth. This brings the company's revenue in the last twelve months to 2.45T, up 1.50% year-over-year. In the fiscal year ending March 31, 2025, Suzuken had annual revenue of 2.40T with 0.56% growth.
Revenue (ttm)
2.45T
Revenue Growth
+1.50%
P/S Ratio
0.18
Revenue / Employee
189.35M
Employees
12,923
Market Cap
431.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.40T | 13.46B | 0.56% |
| Mar 31, 2024 | 2.39T | 71.67B | 3.10% |
| Mar 31, 2023 | 2.31T | 82.05B | 3.67% |
| Mar 31, 2022 | 2.23T | 104.56B | 4.91% |
| Mar 31, 2021 | 2.13T | -85.26B | -3.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Alfresa Holdings | 3.06T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| COSMOS Pharmaceutical | 1.04T |
| HOYA Corporation | 915.21B |
| Sundrug | 833.92B |
| Kusuri No Aoki Holdings | 538.45B |
Suzuken News
- 3 months ago - Suzuken Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha